eli lilly lawsuit tirzepatide FDA's decision creates uncertainty for patients—and leads to a Novo sues Lilly, claiming misleading

"International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 81"

Semaglutide is an FDA-approved medication that has gained attention for its effectiveness in managing weight loss and type 2 diabetes

Our staff will work directly with you and your insurer to determine your coverage and identify financial assistance opportunities

No syringes to explain at airport security

When to reassess If GI symptoms worsen instead of improving over the first 2-3 weeks of a step, if you cannot keep food down, or if you have severe persistent abdominal pain (especially with back radiation), pause and consult a qualified clinician